Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Biomarker Technologies

ID3EAL™ miRNA Knowledge Panels - MiRXES

Read More
Biomarkers for Drug Discovery & Development

Indivumed Biobank

Read More
Genomic Markers & Precision Medicine

Liquid Biopsy (Longitudinal Cell-free Plasma) - Indivumed

Read More
Biomarker Technologies

RNA Sequencing - MiRXES

Read More
Genomic Markers & Precision Medicine

Spatial Transcriptomics Services - Indivumed

Read More
Biomarker Technologies

Whole Exome Sequencing - MiRXES

Read More
Biomarker Technologies

Whole Genome Bisulphite Sequencing - MiRXES

Read More
Biomarker Technologies

Whole Genome Sequencing - MiRXES

Read More
Biomarkers for Clinical Development

Non-Invasive Biomarkers: Aiding Clinical Qualification of Prognostics and Monitoring Biomarkers for Liver Cirrhosis

In this Commentary, we explore how non-invasive biomarkers may be used to diagnose pre-symptomatic NASH in patients without them undergoing invasive biopsies.
Read More
Biomarkers for Clinical Development

The Applicability of Clinical Biomarkers for NASH and Fibrosis

Archana Vijayakumar, Senior Research Scientist I of Fibrosis at Gilead, presents on understanding disease progression and therapeutic efficacy in preclinical models for NASH.
Read More
Biomarkers for Clinical Development

Overcoming Challenges of NASH in Clinical Development

Vincent Mikol, Precision Medicine Head at Sanofi, leads a discussion on navigating the current challenges of NASH in clinical development.
Read More
Biomarkers for Drug Discovery & Development

Treating the Untreatable: Unlocking Precision Medicine Biomarkers for NASH

Introducing PreciNASH, a multidisciplinary consortium strengthening the link between research outputs and clinical applications in NASH disease treatment.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers